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Abstract 
 
For many individuals in treatment for cocaine dependence, weight gain is a substantial problem 
during recovery. This weight gain causes significant distress and seems to increase the risk of 
relapse. The mechanisms underlying cocaine’s effects on weight remain elusive. It is widely 
assumed that this weight gain reflects a metabolic or behavioural compensatory response to the 
cessation of cocaine use. Here we challenge this assumption and outline potential mechanisms 
by which chronic cocaine use produces disturbances in the regulation of fat intake and storage, 
through its effects on the central and peripheral nervous systems, specifically the sympathetic 
nervous system. We hypothesise that the cocaine-induced alteration in fat regulation results in 
cocaine users developing a pronounced appetite for fatty food but keeps their fat mass low. This 
altered fat appetite subsequently leads to excessive weight gain when individuals enter 
treatment and stop using cocaine. Our aim is to shed light on the neurobiological mechanisms 
that may underlie the alterations in eating and fat regulation in cocaine-dependent individuals, 
to open up potential new avenues to support these individuals in recovery. 
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Whilst cocaine is best known for its reinforcing effects and addictive potential, its influence on 
appetite and body weight is less well understood. This is surprising, given that weight gain is a 
substantial problem during recovery from cocaine dependence and is associated with significant 
distress and poorer compliance with treatment. There are currently no guidelines for health care 
professionals on how to address weight change in cocaine-dependent individuals receiving 
treatment. Instead, clinical practice seems to be dominated by the view that this weight gain 
during recovery reflects a compensatory response to restore weight that was previously lost due 
to the appetite suppressant effects of cocaine (1). Another prevailing view is that individuals 
who give up drug-taking replace the drug with food, further increasing the risk of weight gain. 
Neither of these beliefs are really supported by scientific evidence. In fact, the pre-clinical 
evidence shows that cocaine’s anorexigenic effects are acute and transient (2) and are shortly 
followed by a compensatory increase in the consumption of fat and carbohydrates (3). These 
pre-clinical observations are in keeping with the eating patterns that have been reported in 
cocaine-dependent humans (4;5), who show a preference for fat but without concomitant weight 
gain. The mechanisms underlying these effects of cocaine on eating behavior and weight remain 
elusive. Here we aim to turn the spotlight on the effects that cocaine exerts on the central and 
the peripheral, sympathetic nervous systems. These may not only elucidate a variety of 
metabolic disturbances possibly underpinning cocaine users’ preferences for fatty food in spite 
of low body weight, but may also explain the excessive weight gain in abstinent cocaine-
dependent individuals.  
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1. Central nervous effects of cocaine on fat regulation    
1.1 Cocaine’s modulatory effects on fat intake  
Cocaine is a central nervous system stimulant that blocks the reuptake of monoamines. 
However, its addictive potential has mainly been attributed to its ability to inhibit the dopamine 
transporter (DAT), thereby increasing extracellular dopamine (DA) availability in the synaptic 
cleft and stimulating postsynaptic dopamine receptors. It is this sharp increase in extracellular 
dopamine that has been linked to its euphorigenic effect and the desire to take the drug again. 
But could cocaine’s central dopaminergic effects also influence an individual’s food 
preference? Pre-clinical work by Thanos et al. (6) supports this hypothesis. They demonstrated 
that the dopamine D2 receptor (D2-R) agonist bromocriptine, which increases dopaminergic 
neurotransmission in the midbrain, acutely suppresses overall food intake in rats. Once these 
acute effects fade and the animals commence eating, they express a preference for high fat food 
pellets over regular food, possibly reflecting an enhanced motivational drive for fat-rich food 
(6). Similarities between the effects of bromocriptine and cocaine on midbrain dopamine 
transmission have fuelled speculations about whether the compulsive use of food and drugs 
may have a common biochemical origin (7). 
 
Cocaine also inhibits the re-uptake of serotonin (5-HT) via presynaptic serotonin transporters 
(SERT), increasing serotonin availability in the synaptic cleft (8). Serotonergic neurons in the 
brainstem are known to project to hypothalamic regions including the arcuate nucleus, 
increasing appetite by activating postsynaptic 5-HT receptors (e.g. Htr1a) of arcuate nucleus 
neurons (Yadav et al., 2009). Additionally, a number of knockout studies in mice found that the 
inhibition of these 5-HT producing brainstem neurons induced leptin-dependent anorexic 
effects (9). Chronic cocaine exposure may therefore enhance food consumption by modulating 
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5-HT neurotransmission in the arcuate nucleus both directly, via the inhibition of SERT, and 
indirectly by reducing leptin production through its peripheral effects (see section 2). 
 
The specific appetite for fat may however be modulated by cocaine’s excitatory effects on the 
hypothalamic-pituitary-adrenal axis (HPA) through the release of hypothalamic corticotropin-
releasing factor (CRF). Raised levels of circulating glucocorticoids have been linked to both an 
increase in the consumption of calorific food and impaired memory of the calorific ingestion, 
resulting in an overall increase in food intake (10). A more nuanced view on glucocorticoid 
hormones’ influences on diet, however, differentiates the involvement of homeostatic factors 
such as hormones and neuroendocrine signals (i.e. insulin and neuropeptide Y) and non-
homeostatic factors such as changes in motivation on both drug-taking behaviors and eating 
(11;12). Glucocorticoids have been shown to promote the release of neuropeptide Y (NPY) 
whilst inhibiting the anorexigenic modulatory effects of factors like leptin (13), possibly driving 
the increase in appetite. Glucocorticoids also enhance insulin release and higher circulating 
insulin levels are associated with fatty food consumption (14) . There is pre-clinical evidence 
suggesting that insulin may enhance the behavioral effects of cocaine (15). It is conceivable 
that a glucocorticoid-stimulated increase in insulin levels may also underlie cocaine users’ 
preference for a fatty diet. Moreover, the fat-induced increase in insulin levels in cocaine users 
might further be reinforced by insulin’s modulatory effects on dopaminergic neurotransmission 
(16), thereby facilitating the overeating of foods that are specifically high in fat.   
 
Satiety signals, modulated by leptin and insulin, typically regulate the intake of fatty foods. 
Both of these hormones inhibit the activities of appetite-promoting orexin and NPY/AgRP 
neurons in the arcuate nucleus, whilst also promoting the activity of appetite-inhibiting POMC 
neurons. Not only do these two satiety factors converge on the same molecular signaling 
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pathways, including the phosphoinositide 3-kinase (PI-3K) pathway, there also seems to be 
cross-talk between the biochemical responses to leptin and insulin in neurons of the arcuate 
nucleus (17). Thus, chronic cocaine use is likely to interfere with these two satiety signals, 
further facilitating an increase in the consumption of fatty foods. 
 
1.2 Cocaine’s modulatory effects on fat storage   
Despite their high intake of foods rich in fat, cocaine-dependent individuals do not exhibit a 
concomitant increase in body weight. This somewhat paradoxical effect may be because of a 
variety of cocaine-induced metabolic disturbances that could interfere with the regulation of fat 
intake and storage. As outlined in Figure 1, cocaine promotes the production and the release of 
the neuropeptide cocaine and amphetamine regulated transcript (CART) (18), which is 
implicated in the regulation of feeding, satiety and body weight (19). Pre-clinical studies have 
shown that CART, when centrally administered, reduces food intake in the short-term, whilst 
changing lipid metabolism in the long-term (20). This CART-induced shift in the management 
of circulating lipids from deposition to mobilization and oxidation is likely to decrease the 
storage of body fat (20). The direct effects of cocaine on CART may thus explain cocaine users’ 
relatively low body fat in spite of their high fat intake.  
 
2. The effects of cocaine through the periphery   
One of the most notable effects of cocaine use is the concomitant increase in heart rate and 
blood pressure, caused by increased sympathetic nerve activity through the inhibition of the 
noradrenaline transporter (NAT). As a potent sympathomimetic, cocaine increases the 
mobilization of stored lipids, metabolic rate and thermogenesis, subsequently reducing 
adiposity. Importantly, up-regulation of sympathetic nervous system activity has also been 
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linked to a reduction in the production of leptin and increased appetite(21). Cocaine’s 
sympathomimetic effects may therefore explain prior observations in cocaine-dependent men 
with low plasma leptin levels, who reported uncontrolled intake of food high in fat and 
carbohydrates (4). Furthermore, the appetite enhancing effects of reduced leptin production 
coupled with the long-term metabolic effects of cocaine-induced up-regulation of CART 
represent a disconnection between leptin and CART signaling in the negative feedback cycle 
controlling body fat accumulation (20), which might result in a reduction in body weight despite 
increased food consumption in cocaine-dependent individuals. 
 
3. Possible Clinical Implications 
This article aims to challenge prevailing beliefs regarding weight gain in recovering cocaine-
dependent individuals. Specifically, it challenges the widely-held ideas that weight gain 
represents a compensatory metabolic response to a previous appetite-suppressant effect and/or, 
a compensatory behavioral response to the loss of a substance that was compulsively consumed.  
Here, we outline hypotheses about how chronic cocaine use may alter the regulation of fat 
intake and storage. In our view, overeating in chronic cocaine users does not start during 
recovery as widely assumed, but may actually develop during active cocaine use, with the drug 
specifically affecting the choice for the consumption of highly calorific fatty foods. This may 
however, go unnoticed because the consumption of fatty food does not coincide with the acute 
pharmacological actions of the drug, but occurs after a few hours delay, and more importantly, 
it is not accompanied by weight gain. Excessive weight gain only occurs upon the 
discontinuation of cocaine use, as the dietary preference for fat-rich food persists but the effects 
on fat mobilization and oxidation wane. The sudden and excessive weight gain may then come 
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as a surprise to cocaine-dependent individuals, as they may not have noticed any change in their 
dietary food intake to which they could attribute the increase in body weight.  
 
We believe an important clinical implication of the above is the need to incorporate these 
phenomena into our clinical conceptualization of cocaine dependence, and to anticipate them 
during abstinence and recovery. A better understanding of the exact molecular mechanisms 
underlying these metabolic disturbances would be vital to the development of pharmacological 
strategies to address these changes in eating behavior and fat metabolism in these individuals. 
However it is most important for both cocaine dependent individuals and the clinicians who 
treat them, to be aware of these metabolic effects of cocaine or enable them to address these 
early during the recovery process.  
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Figure 1: Possible biochemical and physiological effects of cocaine on monoaminergic 
neurotransmitter systems by inhibiting the reuptake of serotonin (5-HT), dopamine (DA), 
noradrenaline (NA), as indicated by red bar-headed lines. Blockade of the re-uptake increases 
the availability of monoamines in the synaptic cleft, as indicated by squared brackets. The 
excitatory effects of cocaine on the hypothalamic-pituitary-adrenal axis (HPA) and cocaine and 
amphetamine regulated transcript (CART) pathways are indicated by green arrows. Cocaine 
promotes serotonergic signaling resulting in an increase in appetite via increased activation of 
Htr1a/2b receptors of arcuate nucleus (ARN) neurons. Dopaminergic signaling is enhanced 
by cocaine, i.e. activation of dopamine D2 receptors (D2-Rs) leads acutely to satiety, but has 
been suggested to increase fat intake in chronic cocaine users. Cocaine also stimulates CART 
release, which drives short-lived anorexigenic effects. CART, in turn, initiates increased lipid 
mobilization and oxidation; this involves a decrease in adipose lipoprotein lipase activity 
(involved in fat deposition) and uncoupling proteins (UCP) up-regulation. Leptin can also 
stimulate CART release within selective parts of the brain e.g. ARN. Cocaine modulates the 
HPA pathway, increasing corticotrophin-releasing factor (CRF) release, resulting in increased 
adrenocorticotropic hormone (ACTH) release and circulating glucocorticoids. Glucocorticoids 
alter homeostatic and non-homeostatic factors increasing calorie/fat dietary intake in chronic 
cocaine users. Cocaine enhances noradrenergic signaling resulting in increased metabolic rate 
and thermogenesis.  Stimulation of beta-3 adrenergic receptors (β3-Rs) and beta-1 and beta-2 
adrenergic receptors (β1-R and β2-R), increases thermogenesis and reduces leptin production 
respectively. 
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